Showing 4 results for Therapy
Many businesses and academic researchers wishing to pursue cutting-edge research ideas with government support lack the resources to navigate the burdensome paperwork requirements required to win federal grants or contracts. DARPA’s Biological Technologies Office (BTO) has created a simplified proposal process to attract and fund new ideas from just those types of innovators—those operating at the intersection of biology and technology who may never have worked with the Defense Department and may otherwise have remained too daunted to try.
May 17, 2019,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day meeting to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes.
This announcement seeks revolutionary research ideas for topics not being
addressed by ongoing BTO programs or other published solicitations.
DARPA is soliciting innovative proposals to develop (1) new therapeutics
against Department of Defense (DoD)-priority bacterial threats that leverage
host-driven protein degradation or deactivation pathways; and (2) a platform
capability to rapidly develop, screen, and optimize therapeutics against
emerging bacterial threats.